Catheter Precision EBITDA vs. Current Valuation
| VTAK Stock | 0.42 0.01 2.44% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -15.1 M | Current Value -15.9 M | Quarterly Volatility 15.3 M |
For Catheter Precision profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Catheter Precision to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Catheter Precision utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Catheter Precision's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Catheter Precision over time as well as its relative position and ranking within its peers.
Catheter |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share 0.604 | Quarterly Revenue Growth (0.03) | Return On Assets (0.22) | Return On Equity (0.50) |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Catheter Precision Current Valuation vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Catheter Precision's current stock value. Our valuation model uses many indicators to compare Catheter Precision value to that of its competitors to determine the firm's financial worth. Catheter Precision is rated third in ebitda category among its peers. It is rated third in current valuation category among its peers . The company's current value of EBITDA is estimated at (15.87 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Catheter Precision by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Catheter Current Valuation vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Catheter Precision |
| = | (15.11 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Catheter Precision |
| = | 3.92 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Catheter Current Valuation vs Competition
Catheter Precision is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 453.01 Million. Catheter Precision maintains roughly 3.92 Million in current valuation contributing less than 1% to equities under Health Care industry.
Catheter Precision Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Catheter Precision, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Catheter Precision will eventually generate negative long term returns. The profitability progress is the general direction of Catheter Precision's change in net profit over the period of time. It can combine multiple indicators of Catheter Precision, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 29.9 K | 31.4 K | |
| Operating Income | -78.1 M | -74.2 M | |
| Income Before Tax | -70.6 M | -67 M | |
| Total Other Income Expense Net | 7.5 M | 7.9 M | |
| Net Loss | -70.6 M | -67 M | |
| Income Tax Expense | 60.6 M | 63.6 M | |
| Net Interest Income | 347 K | 231.2 K | |
| Interest Income | 347 K | 302.8 K | |
| Net Loss | -70.6 M | -67 M | |
| Net Loss | -28.8 M | -30.3 M | |
| Change To Netincome | -3.4 M | -3.2 M | |
| Net Loss | (12.84) | (13.48) | |
| Income Quality | 0.29 | 0.50 | |
| Net Income Per E B T | 1.15 | 1.09 |
Catheter Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Catheter Precision. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Catheter Precision position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Catheter Precision's important profitability drivers and their relationship over time.
Use Catheter Precision in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catheter Precision position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catheter Precision will appreciate offsetting losses from the drop in the long position's value.Catheter Precision Pair Trading
Catheter Precision Pair Trading Analysis
The ability to find closely correlated positions to Catheter Precision could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catheter Precision when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catheter Precision - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catheter Precision to buy it.
The correlation of Catheter Precision is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catheter Precision moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catheter Precision moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catheter Precision can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Catheter Precision position
In addition to having Catheter Precision in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
To fully project Catheter Precision's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Catheter Precision at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Catheter Precision's income statement, its balance sheet, and the statement of cash flows.